Table 4: Treatments during hospitalization. |
||||
|
All patients (N = 257) n (%) |
Arrhythmia (N = 94) n (%) |
Non-arrhythmia (N = 163) n (%) |
p |
Azithromycin |
162 (63) |
58 (61.7) |
104 (63.8) |
0.737 |
High flow nasal cannula |
38 (14.8) |
23 (24.5) |
15 (9.2) |
0.001 |
Vitamin C |
233 (90.7) |
86 (91.5) |
147 (90.2) |
0.729 |
Vitamin D |
200 (77.8) |
78 (83) |
122 (74.8) |
0.131 |
Zinc |
80 (31.1) |
31 (33) |
49 (30.1) |
0.627 |
N-acetylcysteine |
150 (58.4) |
61 (64.9) |
89 (54.6) |
0.107 |
Oseltamivir |
40 (15.6) |
9 (9.6) |
31 (19) |
0.044 |
Remdesivir |
154 (59.9) |
60 (63.8) |
94 (57.7) |
0.332 |
Favipiravir |
58 (22.6) |
24 (25.5) |
34 (20.9) |
0.388 |
Antibiotic |
124 (48.2) |
51 (54.3) |
73 (44.8) |
0.143 |
Anticoagulant |
197 (76.7) |
80 (85.1) |
117 (71.8) |
0.015 |
Unfractionated heparin |
137 (53.3) |
55 (58.5) |
82 (50.3) |
0.204 |
Low molecular weight heparin |
53 (20.6) |
13 (24.5) |
30 (18.4) |
0.247 |
Fondaparinux |
7 (2.7) |
2 (2.1) |
5 (3.1) |
1 |
Corticosteroid |
90 (35) |
34 (36.2) |
56 (34.4) |
0.769 |
Insulin |
39 (15.2) |
19 (20.2) |
20 (12.3) |
0.087 |
Anti IL-6 |
0 |
0 |
0 |
0 |
Plasma convalescent |
55 (21.4) |
28 (29.8) |
27 (16.6) |
0.013 |
IVIG |
2 (0.8) |
2 (2.1) |
0 |
0.062 |
IL = interleukin. IVIG = intravenous immunoglobulin. |